MENU
ERNA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ernexa Therapeutics (ERNA) Ownership - Who owns Ernexa Therapeutics?
Eterna Therapeutics Inc is a biopharmaceuticals company... Show more
Industry: #Medical Specialties
Profile
Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 212 582-1199
Employees
8
Web
https://www.eternatx.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
9.61M
P/E Ratio
N/A
Total Cash
1.73M
Projected Growth
N/A
Total Debt
684K
Revenue
582K
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash/Share
0.03
Total Debt/Equity
N/A
Revenue/Share
0.04 USD as % of share price
Fundamentals
ERNA
Capitalization
9.61M
P/E Ratio
N/A
Risk (Beta)
2.03
Dividend Yield
N/A
Total Cash
1.73M
Total Cash/Share
0.03
Total Debt
684K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.04%
Revenue
582K
ROE
N/A
Book Value
1.7M
P/B Ratio
5.87
Cash Flow
N/A
Earnings
-3.26
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
257K
Current Ratio
0.80
Current Revenue Per Employee
125.00
Dividends Per Share - Security
N/A
EBITDA
-36.12M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-163.80
Shares Held By Institutions
379K
Shares Outstanding - Current
52.2M
Total Liabilities
3.57M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-37.415
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of biomedical research products in the field of stem cells and regenerative medicine
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1035 Cambridge Street
Phone
+1 212 582-1199
Employees
8
Web
https://www.eternatx.com